Literature DB >> 18266995

Validation of a brief symptom questionnaire (ReQuest in Practice) for patients with gastro-oesophageal reflux disease.

G Rubin1, P Uebel, A Brimo-Hayek, K H Hey, H Doerfler, R C Heading.   

Abstract

BACKGROUND: A clinical need exists for a means of assessing symptom control in patients with gastro-oesophageal reflux disease. The ReQuest questionnaire has been extensively validated for symptom assessment in both erosive and non-erosive gastro-oesophageal reflux disease but was designed for research purposes. We derived a shorter version (ReQuest in Practice) that would be more convenient for clinical practice. AIM: To validate ReQuest in Practice in patients suffering from gastro-oesophageal reflux disease.
METHODS: Multicentre, non-interventional, crossover comparison. Patients completed ReQuest in Practice followed by ReQuest or vice versa. Before and after a planned endoscopy, patients completed the health-related quality of life questionnaire GERDyzer. Internal consistency and the Intraclass Correlation Coefficient were calculated. Construct validity was evaluated by correlation with ReQuest and GERDyzer.
RESULTS: There was high internal consistency of ReQuest in Practice (Cronbach's alpha: 0.9) and a high Intraclass Correlation Coefficient of 0.99. The measurement error of ReQuest in Practice was 4.1. High correlation between ReQuest in Practice and ReQuest (Spearman correlation coefficient: 0.9) and GERDyzer (Spearman correlation coefficient: 0.8) demonstrated construct validity.
CONCLUSIONS: ReQuest in Practice was proven to be valid and reliable. Its close correlation with ReQuest makes it a promising tool to guide the clinical management of patients across the full spectrum of both erosive and non-erosive gastro-oesophageal reflux disease.

Entities:  

Mesh:

Year:  2008        PMID: 18266995     DOI: 10.1111/j.1365-2036.2008.03641.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  12 in total

Review 1.  Beyond the Eckardt Score: Patient-Reported Outcomes Measures in Esophageal Disorders.

Authors:  Y Claire Dorsey; Erin J Song; David A Leiman
Journal:  Curr Gastroenterol Rep       Date:  2021-12-01

2.  Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

Authors:  I M Modlin; R H Hunt; P Malfertheiner; P Moayyedi; E M Quigley; G N J Tytgat; J Tack; R C Heading; G Holtman; S F Moss
Journal:  Digestion       Date:  2009-06-17       Impact factor: 3.216

3.  Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole.

Authors:  Robert C Heading; Hubert Mönnikes; Anne Tholen; Holger Schmitt
Journal:  BMC Gastroenterol       Date:  2011-05-11       Impact factor: 3.067

4.  Diagnosing GORD in Respiratory Medicine.

Authors:  Chris J Timms; Deborah H Yates; Paul S Thomas
Journal:  Front Pharmacol       Date:  2011-07-22       Impact factor: 5.810

5.  The suitability of the GERDyzer instrument in pH-test-proven laryngopharyngeal reflux patients.

Authors:  Cheng-Pin Wu; Wen-Miin Liang; Chen-Chi Wang; Chi-Sen Chang; Hong-Zen Yeh; Jeng-Yuan Hsu; Chung-Wang Ko; Shou-Wu Lee; Shu-Chuan Chang; Fung-Chang Sung; Han-Chung Lien
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

6.  Impact of PPIs on patient focused symptomatology in GERD.

Authors:  Abr Thomson
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

7.  An epidemiological survey of gastroesophageal reflux disease at the digestive endoscopy center in Guangzhou.

Authors:  Gui Chen; Weixing Liu; Wenjing Liao; Lijuan Song; Pingchang Yang; Xiaowen Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-07-21       Impact factor: 3.236

8.  Relief of Night-time Symptoms Associated With Gastroesophageal Reflux Disease Following 4 Weeks of Treatment With Pantoprazole Magnesium: The Mexican Gastroesophageal Reflux Disease Working Group.

Authors:  Juan Carlos López-Alvarenga; William Orr; José Antonio Vargas-Romero; José María Remes-Troche; Miguel Morales-Arámbula; Julio César Soto-Pérez; Gualberto Mateos-Pérez; Sergio Sobrino-Cossío; Oscar Teramoto-Matsubara; Aurelio López-Colombo; Antonio Orozco-Gamiz; Adolfo Saez-Ríos; Araceli Arellano-Plancarte; Jazmin Chiu-Ugalde; Anne Tholen; Silke Horbach; Lars Lundberg; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2013-12-30       Impact factor: 4.924

9.  Factors influencing treatment outcome in patients with gastroesophageal reflux disease: outcome of a prospective pragmatic trial in Asian patients.

Authors:  Khean Lee Goh; Kee Don Choi; Myung-Gyu Choi; Tsai-Yuan Hsieh; Hwoon-Yong Jung; Han-Chung Lien; Jayaram Menon; Steven Mesenas; Hyojin Park; Bor-Shyang Sheu; Justin Cy Wu
Journal:  BMC Gastroenterol       Date:  2014-09-09       Impact factor: 3.067

10.  Gastroesophageal reflux disease symptoms in the Greek general population: prevalence and risk factors.

Authors:  Nikolaos Spantideas; Eirini Drosou; Anastasia Bougea; Dimitrios Assimakopoulos
Journal:  Clin Exp Gastroenterol       Date:  2016-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.